Article Menu
-
Academic Editor
Brian Gabrielli
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Mohr, P.
- Scherrer, E.
- Assaf, C.
- Bender, M.
- Berking, C.
- Chandwani, S.
- Eigentler, T.
- Grimmelmann, I.
- Gutzmer, R.
- Haferkamp, S.
- Hassel, J. C.
- Hauschild, A.
- Herbst, R.
- Jiang, R.
- Kähler, K. C.
- Krepler, C.
- Kreuter, A.
- Leiter, U.
- Loquai, C.
- Meier, F.
- Pföhler, C.
- Rudolph, A.
- Schadendorf, D.
- Schiavone, M.
- Schley, G.
- Terheyden, P.
- Ugurel, S.
- Ulrich, J.
- Utikal, J.
- Weishaupt, C.
- Welzel, J.
- Weichenthal, M.
- on Google Scholar
- Mohr, P.
- Scherrer, E.
- Assaf, C.
- Bender, M.
- Berking, C.
- Chandwani, S.
- Eigentler, T.
- Grimmelmann, I.
- Gutzmer, R.
- Haferkamp, S.
- Hassel, J. C.
- Hauschild, A.
- Herbst, R.
- Jiang, R.
- Kähler, K. C.
- Krepler, C.
- Kreuter, A.
- Leiter, U.
- Loquai, C.
- Meier, F.
- Pföhler, C.
- Rudolph, A.
- Schadendorf, D.
- Schiavone, M.
- Schley, G.
- Terheyden, P.
- Ugurel, S.
- Ulrich, J.
- Utikal, J.
- Weishaupt, C.
- Welzel, J.
- Weichenthal, M.
- on PubMed
- Mohr, P.
- Scherrer, E.
- Assaf, C.
- Bender, M.
- Berking, C.
- Chandwani, S.
- Eigentler, T.
- Grimmelmann, I.
- Gutzmer, R.
- Haferkamp, S.
- Hassel, J. C.
- Hauschild, A.
- Herbst, R.
- Jiang, R.
- Kähler, K. C.
- Krepler, C.
- Kreuter, A.
- Leiter, U.
- Loquai, C.
- Meier, F.
- Pföhler, C.
- Rudolph, A.
- Schadendorf, D.
- Schiavone, M.
- Schley, G.
- Terheyden, P.
- Ugurel, S.
- Ulrich, J.
- Utikal, J.
- Weishaupt, C.
- Welzel, J.
- Weichenthal, M.
Need Help?
Order Article Reprints
Journal: Cancers, 2022
Volume: 14
Number: 1804
1804
Article:
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
Authors:
by
Peter Mohr, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, Jessica C. Hassel, Axel Hauschild, Rudolf Herbst, Ruixuan Jiang, Katharina C. Kähler, Clemens Krepler, Alexander Kreuter, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Claudia Pföhler, Anja Rudolph, Dirk Schadendorf, Maximo Schiavone, Gaston Schley, Patrick Terheyden, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Julia Welzel and Michael Weichenthaladd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/14/7/1804
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Mohr, P.; Scherrer, E.; Assaf, C.; Bender, M.; Berking, C.; Chandwani, S.; Eigentler, T.; Grimmelmann, I.; Gutzmer, R.; Haferkamp, S.; et al. Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 2022, 14, 1804. https://doi.org/10.3390/cancers14071804
Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, Grimmelmann I, Gutzmer R, Haferkamp S, et al. Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers. 2022; 14(7):1804. https://doi.org/10.3390/cancers14071804
Chicago/Turabian StyleMohr, Peter, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, and et al. 2022. "Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany" Cancers 14, no. 7: 1804. https://doi.org/10.3390/cancers14071804
APA StyleMohr, P., Scherrer, E., Assaf, C., Bender, M., Berking, C., Chandwani, S., Eigentler, T., Grimmelmann, I., Gutzmer, R., Haferkamp, S., Hassel, J. C., Hauschild, A., Herbst, R., Jiang, R., Kähler, K. C., Krepler, C., Kreuter, A., Leiter, U., Loquai, C., ... Weichenthal, M. (2022). Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers, 14(7), 1804. https://doi.org/10.3390/cancers14071804
